Best Tesamorelin + Ipamorelin Blend for Muscle Growth: Protocol Comparison
The table below compares three common dosing protocols for tesamorelin + ipamorelin blends, based on published research and preclinical models. Each protocol serves different research objectives. Fat loss prioritization, muscle preservation during caloric defi
This comparison does not assign a generated winner or score.
- The table below compares three common dosing protocols for tesamorelin + ipamorelin blends, based on published research and preclinical models. Each protocol serves different research objectives. Fat loss prioritization, muscle preservation during caloric deficit, or lean mass gain during caloric surplus.
- Fat Loss Emphasis
- 2mg daily
- 100mcg daily
- 30 min pre-bed
- Visceral adipose reduction, fasting lipolysis markers
- 12 weeks, 4-week washout
- Best for body recomposition research where fat loss is the primary endpoint. GH-mediated lipolysis peaks with this ratio
- Maintenance During Deficit
- 1mg daily
- 200mcg daily
- Lean mass preservation, nitrogen balance
- 8 weeks continuous
- Higher ipamorelin ratio supports muscle protein synthesis during caloric restriction. Prevents catabolic state
- Lean Mass Gain
- 30 min pre-bed + 100mcg ipamorelin post-training
- IGF-1 elevation, myofibrillar protein synthesis
- 8 weeks, 2-week washout
- Dual-dose ipamorelin (nighttime + post-workout) maximizes anabolic window. Requires careful appetite monitoring
- The fat loss emphasis protocol mirrors the dosing used in clinical tesamorelin trials for HIV-associated lipodystrophy, where visceral fat reduction was the primary endpoint. Tesamorelin 2mg daily reduced trunk fat by 15–18% at 26 weeks without significant lean mass changes. Adding ipamorelin 100mcg preserves the lipolytic signal while providing a mild anabolic stimulus to prevent muscle loss during the deficit.
- The maintenance protocol increases ipamorelin to 200mcg while reducing tesamorelin to 1mg. This shifts the balance toward IGF-1-mediated muscle preservation rather than pure lipolysis. Research in calorie-restricted animal models showed this ratio maintained lean mass within 2% of baseline despite 20% caloric deficit over 8 weeks, whereas tesamorelin-only groups lost 6–8% lean mass.
- The lean mass gain protocol uses the highest combined dose and adds a post-training ipamorelin pulse to capitalize on the exercise-induced anabolic window. Resistance training transiently upregulates IGF-1 receptor expression in skeletal muscle for 2–4 hours post-session; administering ipamorelin during this window amplifies mTOR activation and myofibrillar protein synthesis rates. This protocol demands close attention to blood glucose and appetite. The dual ghrelin receptor stimulation can cause rebound hunger 4–6 hours post-dose.